Integra LifeSciences Holdings Corporation (IART) Debt/EBITDA US GAAP (year values) |
||||||||
| 2022 | 2023 | 2023 | 2024 | 2025 | LTM ? | |||
| Debt/EBITDA | 3.05 | 3.58 | 5.36 | 8.85 | -5.42 | 0.15 | ||
| Changes by years, y/y, % | -3% | +17% | +50% | +65% | -161% | |||
Integra LifeSciences Holdings Corporation. Debt/EBITDA
Integra LifeSciences Holdings Corporation. Debt/EBITDA, changes, %
Integra LifeSciences Holdings Corporation (IART) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| Debt/EBITDA | 9.68 | -5.30 | -5.55 | -5.42 | 0.15 | 0.15 | ||
| Changes by years, y/y, % | +56% | -167% | -161% | -161% | -98% | |||
| Changes by quarters, q/q, % | +9% | -155% | +5% | -2% | -103% | |||